Type 17-specific immune pathways are active in early spondyloarthritis.

Catherine D HughesSarah E RyanKathryn J A SteelMichelle D van den Beukel Leendert Adrianus TrouwKarin A J van SchieRené E M ToesBina MenonBruce W Kirkham Leonie S Taams

Published in: RMD open (2023)

These results suggest that adaptive T cell cytokine pathways differ not only between RA and SpA but also seronegative UIA early in the disease process, with a particular activation of Tc17 pathways in early SpA.

Keyphrases

rheumatoid arthritis